These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25075064)

  • 1. Treatment sequence of aromatase inhibitors and radiotherapy and long-term outcomes of breast cancer patients.
    Ishitobi M; Shiba M; Nakayama T; Motomura K; Koyama H; Nishiyama K; Tamaki Y
    Anticancer Res; 2014 Aug; 34(8):4311-4. PubMed ID: 25075064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer.
    Ishitobi M; Komoike Y; Motomura K; Koyama H; Nishiyama K; Inaji H
    Anticancer Res; 2009 Nov; 29(11):4791-4. PubMed ID: 20032437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sequential study of radiotherapy and hormonal therapy in breast cancer patients undergoing mastectomy or conservative surgery].
    Wang XC; Huang XB; Zhang WD; Liu MZ; Guang XX; Liu XQ
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1964-9. PubMed ID: 19950570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment.
    Harris EE; Christensen VJ; Hwang WT; Fox K; Solin LJ
    J Clin Oncol; 2005 Jan; 23(1):11-6. PubMed ID: 15545665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concurrent use of aromatase inhibitors and radiotherapy induces echocardiographic changes in patients with breast cancer.
    Skyttä T; Tuohinen S; Virtanen V; Raatikainen P; Kellokumpu-Lehtinen PL
    Anticancer Res; 2015 Mar; 35(3):1559-66. PubMed ID: 25750311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
    J Clin Oncol; 2005 Aug; 23(22):5178-87. PubMed ID: 15998905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen.
    Freedman GM; Anderson P; Li T; Ross E; Swaby R; Goldstein L
    Cancer; 2006 Dec; 107(11):2552-8. PubMed ID: 17061250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiotherapy on older and oldest breast cancer patients after conservative surgery: a retrospective analysis.
    Fiorica F; Berretta M; Ursino S; Fisichella R; Lleshi A; Fiorica G; Stefanelli A; Zini G; Tirelli U; Zanghi A; Cappellani A; Berretta S; Cartei F
    Arch Gerontol Geriatr; 2012; 55(2):283-8. PubMed ID: 22037244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
    Azria D; Belkacemi Y; Romieu G; Gourgou S; Gutowski M; Zaman K; Moscardo CL; Lemanski C; Coelho M; Rosenstein B; Fenoglietto P; Crompton NE; Ozsahin M
    Lancet Oncol; 2010 Mar; 11(3):258-65. PubMed ID: 20138810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
    Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.
    Pierce LJ; Hutchins LF; Green SR; Lew DL; Gralow JR; Livingston RB; Osborne CK; Albain KS
    J Clin Oncol; 2005 Jan; 23(1):24-9. PubMed ID: 15545669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results.
    Knauerhase H; Strietzel M; Gerber B; Reimer T; Fietkau R
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1048-55. PubMed ID: 18359170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor.
    Markopoulos C
    Surg Oncol; 2008 Aug; 17(2):113-28. PubMed ID: 18178077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and physician perceptions on continuing aromatase inhibitors beyond the 5-year mark.
    Gandhi S; Towns K; Verma S
    Breast J; 2011; 17(6):620-9. PubMed ID: 21943336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?
    Aapro M; van de Velde CJ; Markopoulos C; Bartlett JM; Putter H; Coleman RE
    Breast; 2013 Aug; 22(4):488-94. PubMed ID: 23454040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients.
    Kunovac Kallak T; Baumgart J; Stavreus Evers A; Sundström Poromaa I; Moby L; Kask K; Norjavaara E; Kushnir MM; Bergquist J; Nilsson K
    Climacteric; 2012 Oct; 15(5):473-80. PubMed ID: 22324859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM
    Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients.
    Eggemann H; Ignatov A; Smith BJ; Altmann U; von Minckwitz G; Röhl FW; Jahn M; Costa SD
    Breast Cancer Res Treat; 2013 Jan; 137(2):465-70. PubMed ID: 23224235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.